BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 30977256)

  • 1. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
    Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
    Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease.
    Chahine J; Kadri AN; Gajulapalli RD; Krishnaswamy A; Mick S; Perez O; Lak H; Nair RM; Montane B; Tak J; Tuzcu EM; Griffin B; Svensson LG; Harb SC; Kapadia SR
    JACC Cardiovasc Interv; 2019 Nov; 12(22):2299-2306. PubMed ID: 31678084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
    Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
    Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
    Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Schoechlin S; Brennemann T; Allali A; Ruile P; Jander N; Allgeier M; Gick M; Richardt G; Neumann FJ; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2018 May; 91(6):E56-E63. PubMed ID: 29105984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis.
    Ielasi A; Latib A; Sacco FM; Costopoulos C; Figini F; Grimaldi A; Naim C; Maisano F; Chieffo A; Montorfano M; Alfieri O; Colombo A
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):286-95. PubMed ID: 25643194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of left ventricular mechanics after transcatheter aortic valve implantation: effects of baseline ventricular function and postprocedural aortic regurgitation.
    Poulin F; Carasso S; Horlick EM; Rakowski H; Lim KD; Finn H; Feindel CM; Greutmann M; Osten MD; Cusimano RJ; Woo A
    J Am Soc Echocardiogr; 2014 Nov; 27(11):1133-42. PubMed ID: 25125314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of valvular resistance on aortic regurgitation after transcatheter aortic valve replacement according to the type of prosthesis.
    Asami M; Pilgrim T; Stortecky S; Heg D; Roost E; Windecker S; Hunziker L
    Clin Res Cardiol; 2019 Dec; 108(12):1343-1353. PubMed ID: 30929034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Silaschi M; Conradi L; Wendler O; Schlingloff F; Kappert U; Rastan AJ; Baumbach H; Holzhey D; Eichinger W; Bader R; Treede H
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1345-1351. PubMed ID: 29171730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.
    Harrison JK; Hughes GC; Reardon MJ; Stoler R; Grayburn P; Hebeler R; Liu D; Chang Y; Popma JJ;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):168-175. PubMed ID: 28104211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
    Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
    PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
    Murdoch DJ; Sathananthan J; Hensey M; Alu MC; Liu Y; Crowley A; Wood D; Cheung A; Ye J; Feldman T; Hahn RT; Jaber WA; Mack MJ; Malaisrie SC; Leon MB; Webb JG
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):981-986. PubMed ID: 32118351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement.
    Crouch G; Tully PJ; Bennetts J; Sinhal A; Bradbrook C; Penhall AL; De Pasquale CG; Baker RA; Selvanayagam JB
    J Cardiovasc Magn Reson; 2015 May; 17(1):32. PubMed ID: 25953135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures.
    Pibarot P; Simonato M; Barbanti M; Linke A; Kornowski R; Rudolph T; Spence M; Moat N; Aldea G; Mennuni M; Iadanza A; Amrane H; Gaia D; Kim WK; Napodano M; Baumbach H; Finkelstein A; Kobayashi J; Brecker S; Don C; Cerillo A; Unbehaun A; Attias D; Nejjari M; Jones N; Fiorina C; Tchetche D; Philippart R; Spargias K; Hernandez JM; Latib A; Dvir D
    JACC Cardiovasc Interv; 2018 Jan; 11(2):133-141. PubMed ID: 29348008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.